Table III.
Clinical characteristics | HR (95% CI) | P-value |
---|---|---|
ECOG (0/1 vs. 2) | 0.691 (0.176–2.710) | 0.596 |
N stage (negative vs. positive) | 0.466 (0.110–1.983) | 0.302 |
ctDNA status in first post-radiation plasma (negative vs. positive) | 0.183 (0.049–0.678) | 0.011 |
OS, overall survival; HR, hazard ratio; ECOG, Eastern Cooperative Oncology Group; ct, circulating tumor.